{"id":484074,"title":"Risk classification guide for drug good manufacturing practices observations - profile page - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T22:54:33.124000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/risk-classification-drug-gmp-observations-0023.html?wbdisable=true","snippet":"Risk classification guide for drug good manufacturing practices observations (GUI-0023) - Summary Overview These guidelines establish the approach applied for both the attribution of risk ratings to observations noted during drug establishment inspections, and the overall rating…","rawSnapshotUrl":"/api/snapshots/raw/484074","browseUrl":"https://replay.healtharchive.ca/job-6/20260106225433/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/risk-classification-drug-gmp-observations-0023.html?wbdisable=true#ha_snapshot=484074","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}